| Two antioxidant 2, 5-disubstituted-1, 3, 4-oxadiazoles (CoViTris2020 and ChloViD2020): successful repurposing against COVID-19 as the first potent multitarget anti-SARS-CoV-2 drugs AM Rabie New Journal of Chemistry 45 (2), 761-771, 2021 | 76 | 2021 |
| Potent inhibitory activities of the adenosine analogue cordycepin on SARS-CoV-2 replication AM Rabie Acs Omega 7 (3), 2960-2969, 2022 | 72 | 2022 |
| Design, synthesis, and biological evaluation of novel 5-substituted-2-(3, 4, 5-trihydroxyphenyl)-1, 3, 4-oxadiazoles as potent antioxidants AM Rabie, AS Tantawy, SMI Badr Am J Org Chem 6 (2), 54-80, 2016 | 53 | 2016 |
| Potent toxic effects of Taroxaz-104 on the replication of SARS-CoV-2 particles AM Rabie Chemico-Biological Interactions 343, 109480, 2021 | 43 | 2021 |
| Teriflunomide: a possible effective drug for the comprehensive treatment of COVID-19 AM Rabie Current research in pharmacology and drug discovery 2, 100055, 2021 | 41 | 2021 |
| Novel investigational anti-SARS-CoV-2 agent ensitrelvir “S-217622”: A very promising potential universal broad-spectrum antiviral at the therapeutic frontline of coronavirus … WA Eltayb, M Abdalla, AM Rabie ACS omega 8 (6), 5234-5246, 2023 | 38 | 2023 |
| Cyanorona-20: The first potent anti-SARS-CoV-2 agent AM Rabie International Immunopharmacology 98, 107831, 2021 | 32 | 2021 |
| Efficacious preclinical repurposing of the nucleoside analogue didanosine against COVID-19 polymerase and exonuclease AM Rabie ACS omega 7 (25), 21385-21396, 2022 | 30 | 2022 |
| CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy AM Rabie Molecular Diversity 25, 1839-1854, 2021 | 30 | 2021 |
| Design, synthesis, and biological evaluation of new 5-substituted-1, 3, 4-thiadiazole-2-thiols as potent antioxidants AM Rabie, AS Tantawy, SMI Badr Researcher 10 (7), 21-43, 2018 | 27 | 2018 |
| Discovery of Taroxaz-104: The first potent antidote of SARS-CoV-2 VOC-202012/01 strain AM Rabie Journal of Molecular Structure 1246, 131106, 2021 | 25 | 2021 |
| Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug AM Rabie Chemical Papers 75, 4669-4685, 2021 | 25 | 2021 |
| Forodesine and Riboprine Exhibit Strong Anti-SARS-CoV-2 Repurposing Potential: In Silico and In Vitro Studies AM Rabie, M Abdalla ACS bio & med Chem Au 2 (6), 565-585, 2022 | 24 | 2022 |
| Evaluation of a series of nucleoside analogs as effective anticoronaviral-2 drugs against the Omicron-B. 1.1. 529/BA. 2 subvariant: a repurposing research study AM Rabie, M Abdalla Medicinal Chemistry Research 32 (2), 326-341, 2023 | 18 | 2023 |
| Potent dual polymerase/exonuclease inhibitory activities of antioxidant aminothiadiazoles against the COVID-19 omicron virus: a promising in silico/in vitro repositioning … AM Rabie, WA Eltayb Molecular Biotechnology, 1-20, 2023 | 17 | 2023 |
| Dual computational and biological assessment of some promising nucleoside analogs against the COVID-19-Omicron variant M Abdalla, AM Rabie Computational Biology and Chemistry 104, 107768, 2023 | 16 | 2023 |
| New Potential Inhibitors of Coronaviral Main Protease (CoV-Mpro): Strychnine Bush, Pineapple, and Ginger could be Natural Enemies of COVID-19 AM Rabie International Journal of New Chemistry (IJNC) 9 (3), 433-445, 2022 | 16 | 2022 |
| Promising experimental anti-SARS-CoV-2 agent “SLL-0197800”: the prospective universal inhibitory properties against the coming versions of the coronavirus AM Rabie, MA Abdel-Dayem, M Abdalla ACS omega 8 (39), 35538-35554, 2023 | 10 | 2023 |
| International Journal of New Chemistry AM Rabie Int. J. New. Chem 9 (3), 433-445, 2022 | 10 | 2022 |
| COVID-19 and sexual dysfunction in men: SARS-CoV-2 in the testes AM Rabie Sexologies 30 (4), e141-e148, 2021 | 9 | 2021 |
Mohnad AbdallaUniversity of Science and Technology of ChinaVerified email at mail.ustc.edu.cn
